No longer trading

Acquired by Gilead Sciences, Inc.

The acquisition closed on April 28, 2026 (SEC 8-K 2.01). Its last closing price was on April 27, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from April 20, 2026. Source: SEC 8-K 2.01

ACLX

Arcellx, Inc. ACLX

NasdaqMid CapHealthcare

Final 13F Pro quality score

Final rank #2,802 of 2,819 · as of April 20, 2026

Why it scores 8Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$1.65M

Quarter to Dec 31

Net income

$-58.11M

Quarter to Dec 31

Free cash flow

$-58.94M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$3.43M total
DekaBank Deutsche Girozentrale
$3.43M0.0%
IFP Advisors, Inc
$1.5K+8.3%
See all 2 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q4 2025
EDGAR

Net Income

Q4 2025
EDGAR

EPS (Diluted)

Q4 2025
EDGAR

ROIC

Q4 2025
EDGAR

Free Cash Flow

Q4 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ACLX

Earnings Per Share

13fpro.ai/company/ACLX

Loading ratio trend…

ACLX key financials by period

Reported revenue, net income and operating margin by fiscal year, from Arcellx, Inc.'s annual filings on SEC EDGAR.

Arcellx, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$22.3M$-228.9M—
FY 2024$107.9M$-107.3M-127.5%
FY 2023$110.3M$-70.7M-81.5%
Source: ACLX filings on SEC EDGAR →

About Arcellx, Inc. (ACLX): stock profile, AI score and financials

Acquired by Gilead Sciences, Inc.: Arcellx, Inc. (ACLX) no longer trades and has left 13F Pro's AI-ranked universe. The acquisition closed on April 28, 2026 (SEC 8-K 2.01). Its last closing price was on April 27, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from April 20, 2026. Arcellx, Inc. (ACLX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks ACLX using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q4 2025), Arcellx, Inc. reports quarterly revenue of $1.7M, net income of $-58.1M, free cash flow of $-58.9M. ACLX trades on the Nasdaq exchange and files with the SEC under CIK 1786205. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Arcellx, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1786205 →